Nigerian Doctor, Onyeama Ogbuagbu, Identified As Key Figure In Pfizer’s COVID-19 Vaccine Breakthrough

Dr Onyema Ogbuagbu, a Nigerian doctor, has been identified as a key figure in the research that led United States pharmaceutical company, Pfizer, to develop the first effective COVID-19 vaccine.

Speaking in an interview with ABC News on the vaccine, he said although doses will be unavailable to everyone at first, massive distribution was expected to take off in the first quarter of 2021.

Read:  Tech Youtuber Fisayo Fosudo explains E-SIM technology with MTN Nigeria

Pfizer said it would launch a pilot in four states in the United States but there have been concerns as the vaccine needs to be stored at -94 degrees Fahrenheit (-70 degree Celsius), a challenge Ogbuagbu said would be overcome soon.

Read:  Meet mother of 4 selling roasted plantain ‘Boli’ with digital technology in PH (Video)

Ogbuagbu is an Associate Professor of Medicine and Infectious Disease Specialist at Yale School of Medicine, who graduated in 2003 from the University of Calabar with a degree in medicine.


Related posts

Boston-based Nigerian Teams up with Lagos-based Developer to Build E-commerce Platform for Africans Only.


Nigerian man builds soak away that can generate gas for cooking, electricity.


IoT Africa introduces Sigfox to Nigeria, boosts infrastructure with LPWAN.


Tesla Magnetic Resonance Imaging: Eze Applauds Prof. Ugboma, UPTH Management Team


Pan African Payments Company Cellulant acquires PSP License in Ghana as it rolls out a digital payments solution for businesses.


Nigerian startups that raised above $100 million in 2021.


Leave a Comment